Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH

J Thromb Haemost. 2022 Jul;20(7):1735-1743. doi: 10.1111/jth.15732. Epub 2022 May 15.

Abstract

Severe congenital protein C deficiency (SCPCD) is rare and there is currently substantial variation in the management of this condition. A joint project by three Scientific and Standardization Committees of the ISTH: Plasma Coagulation Inhibitors, Pediatric/Neonatal Thrombosis and Hemostasis, and Women's Health Issues in Thrombosis and Hemostasis, was developed to review the current evidence and help guide on diagnosis and management of SCPCD. We provide a summary of the clinical presentations, differential diagnoses, appropriate investigations to confirm the diagnosis, approaches for management of the acute situation, and options for long-term management including subsequent pregnancies. We finally provide a set of recommendations to help in this regard.

Keywords: children; disseminated intravascular coagulation; neonates; purpura fulminans; thrombosis.

MeSH terms

  • Child
  • Disseminated Intravascular Coagulation*
  • Female
  • Hemostasis
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Protein C Deficiency* / diagnosis
  • Thrombosis* / diagnosis
  • Thrombosis* / therapy